¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

¼­¿ï¼º¸ðº´¿ø ´ëÇÑ°íÇ÷¾ÐÇÐȸ Æó°íÇ÷¾Ð¿¬±¸È¸ Á¦4ȸ Çмú¿¬·Ê½ÉÆ÷Áö¾ö : 2019-11-02

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
¼­¿ï¼º¸ðº´¿ø ´ëÇÑ°íÇ÷¾ÐÇÐȸ Æó°íÇ÷¾Ð¿¬±¸È¸ Á¦4ȸ Çмú¿¬·Ê½ÉÆ÷Áö¾ö : 2019-11-02
±³À°ÀÏÀÚ : 2019-11-02
±³À°Àå¼Ò : ¼­¿ï¼º¸ðº´¿ø ÀÇ»ý¸í»ê¾÷¿¬±¸¿ø  
±³À°ÁÖÁ¦ : ´ëÇÑ°íÇ÷¾ÐÇÐȸ Æó°íÇ÷¾Ð¿¬±¸È¸ Á¦4ȸ Çмú¿¬·Ê½ÉÆ÷Áö¾ö
ÁÖÃÖ±â°ü : ´ëÇÑ°íÇ÷¾ÐÇÐȸ
´ã´çÀÚ : Á¤º°
¿¬¶ôó : 02-565-3350  
À̸ÞÀÏ : ksh@koreanhypertension.org      
±³À°Á¾·ù : ³»°ú, Á¤Çü¿Ü°ú, ÈäºÎ¿Ü°ú      
Âü¼®¿¹»óÀοø : 600¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 7 ½Ã°£ 35ºÐ  
¼¼ºÎ¼ö°­·á : 20,000¿ø      
ºñ°í »çÀüµî·Ï 1¸¸¿ø / ÇöÀåµî·Ï 2¸¸¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-02 ¼­¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °­´ç 08:30~08:45 History of pulmonary hypertension  ¹ÚÀçÇü(Ãæ³²ÀÇ´ë ¼øȯ±â ³»°ú) 
±³À°½Ã°£ 11-02 ¼­¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °­´ç 08:45~09:00 Epidemiology of pulmonary hypertension and suggestion for Korean registry  ÀÌÁÖÈñ(ÃæºÏÀÇ´ë ¼øȯ±â ³»°ú) 
±³À°½Ã°£ 11-02 ¼­¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °­´ç 09:00~09:15 Genetic evaluation of pulmonary hypertension and its clinical implication  ÀÌ¿µÀç(°¡ÃµÀÇ´ë »ýÈ­Çаú) 
±³À°½Ã°£ 11-02 ¼­¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °­´ç 09:15~09:30 Combination treatment of selective pulmonary vasodilator for pulmonary hypertension  Á¤Á¶¿ø(¿¬¼¼ÀÇ´ë ¼Ò¾Æ½ÉÀå°ú) 
Åä·Ð 11-02 ¼­¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °­´ç 09:30~09:45 Discussion  ÃÖ¼ºÀç °í·ÁÀÇ´ë ·ù¸¶Æ¼½º³»°ú/Àå¼ÒÀÍ ¼¼Á¾º´¿ø ¼Ò¾Æ½ÉÀå°ú/Çã¶õ ÇѾçÀÇ´ë ½ÉÀå³»°ú(ÃÖ¼ºÀç °í·ÁÀÇ´ë ·ù¸¶Æ¼½º³»°ú/Àå¼ÒÀÍ ¼¼Á¾º´¿ø ¼Ò¾Æ½ÉÀå°ú/Çã¶õ ÇѾçÀÇ´ë ½ÉÀå³»°ú) 
È޽Ġ11-02 ¼­¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °­´ç 09:45~10:05 Coffee break  () 
±³À°½Ã°£ 11-02 ¼­¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °­´ç 10:05~10:20 CTEPH 2019  Hiromi Matsubara(National Hospital Organization Okayama Medical Center) 
±³À°½Ã°£ 11-02 ¼­¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °­´ç 10:20~10:35 Medical devices for pulmonary hypertension  ¼ÛÁø¿µ(¼º±Õ°üÀÇ´ë ¼Ò¾Æ½ÉÀå°ú) 
±³À°½Ã°£ 11-02 ¼­¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °­´ç 10:35~10:50 Surgical treatment for pulmonary hypertension  À±¿µ³²(¿¬¼¼ÀÇ´ë ÈäºÎ¿Ü°ú) 
±³À°½Ã°£ 11-02 ¼­¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °­´ç 10:50~11:05 Anesthesiology for the patients with pulmonary hypertension  À念Àº(¼­¿ïÀÇ´ë ¸¶ÃëÅëÁõÀÇÇаú) 
Åä·Ð 11-02 ¼­¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °­´ç 11:05~11:20 Discussion  ¼ÕÀϼ® °æÈñÀÇ´ë ¼øȯ±â³»°ú/Àº¿µ¹Î °­³²¼¼ºê¶õ½ºº´¿ø ¼Ò¾Æ½ÉÀå°ú/À̼®ÀÎ °¡ÃµÀÇ´ë ÈäºÎ¿Ü°ú(¼ÕÀϼ® °æÈñÀÇ´ë ¼øȯ±â³»°ú/Àº¿µ¹Î °­³²¼¼ºê¶õ½ºº´¿ø ¼Ò¾Æ½ÉÀå°ú/À̼®ÀÎ °¡ÃµÀÇ´ë ÈäºÎ¿Ü°ú) 
±³À°½Ã°£ 11-02 ¼­¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °­´ç 11:20~11:35 Taiwan PH Guideline  Kuo Yang Wang(Taichung China Medical University Hospital) 
±³À°½Ã°£ 11-02 ¼­¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °­´ç 11:35~11:50 Japan PH Guideline  Takeshi Ogo(National Cerebral and Cardiovascular Center) 
±³À°½Ã°£ 11-02 ¼­¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °­´ç 11:50~12:05 China PH Guideline  Zhi-Cheng Jing(Fu Wai Hospital & National Center for Cardiovascular disease) 
±³À°½Ã°£ 11-02 ¼­¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °­´ç 12:05~12:20 Proposed Ideas of EASOPH PH Guideline  Wook-Jin Chung(Gachon University Gil Medical Center) 
½Ä»ç 11-02 ¼­¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °­´ç 12:20~13:20 Lunch  () 
±³À°½Ã°£ 11-02 ¼­¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °­´ç 13:20~13:40 Pulmonary hypertension in my life  ³ëÁ¤ÀÏ(¼¼Á¾º´¿ø ¼Ò¾Æ½ÉÀå°ú) 
±³À°½Ã°£ 11-02 ¼­¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °­´ç 13:40~14:10 How can we diagnose and treat the patients of Pulmonary Hypertension in Heart Failure  Stephan Rosenkranz(University of Cologne) 
±³À°½Ã°£ 11-02 ¼­¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °­´ç 14:10~14:40 Could we recommend pregnancy in female PAH patient?  Hiromi Matsubara(National Hospital Organization Okayama Medical Center) 
Åä·Ð 11-02 ¼­¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °­´ç 14:40~14:50 Discussion  ÃÖÁø¿À ¼º±Õ°üÀÇ´ë ¼øȯ±â³»°ú/³ªÁø¿À °í·ÁÀÇ´ë ¼øȯ±â³»°ú/À§Áø °¡ÃµÀÇ´ë ½ÉÀå³»°ú/ÀÌÁÖÈñ ÃæºÏÀÇ´ë ¼øȯ±â³»°ú(ÃÖÁø¿À ¼º±Õ°üÀÇ´ë ¼øȯ±â³»°ú/³ªÁø¿À °í·ÁÀÇ´ë ¼øȯ±â³»°ú/À§Áø °¡ÃµÀÇ´ë ½ÉÀå³»°ú/ÀÌÁÖÈñ ÃæºÏÀÇ´ë ¼øȯ±â³»°ú) 
±³À°½Ã°£ 11-02 ¼­¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °­´ç 14:50~15:05 Transition of pediatric patient with pulmonary hypertension  ±è±â¹ü(¼­¿ïÀÇ´ë ¼Ò¾Æ½ÉÀå°ú) 
±³À°½Ã°£ 11-02 ¼­¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °­´ç 15:05~15:20 Pregnancy and delivery in the patients with pulmonary hypertension  ±è¹ÌÁ¤(°¡Å縯ÀÇ´ë ÀÎõ¼º¸ðº´¿ø) 
±³À°½Ã°£ 11-02 ¼­¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °­´ç 15:20~15:35 Psychosocial support for patients with pulmonary hypertension  ÀÌÁ¤(¼­¿ïÀÇ´ë ½Å°æÁ¤½Å°ú) 
±³À°½Ã°£ 11-02 ¼­¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °­´ç 15:35~15:50 Palliative care for the patients with advanced pulmonary hypertension  ±è¹Î¼±(¼­¿ïÀÇ´ë ¿ÏÈ­ÀÇ·á) 
Åä·Ð 11-02 ¼­¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °­´ç 15:50~16:05 Discussion  ¹ÚÂù¼® °¡Å縯ÀÇ´ë ¼øȯ±â³»°ú/³ª½Â¿ø ¿ï»êÀÇ´ë È£Èí±â³»°ú/¾È°æÁø °¡ÃµÀÇ´ë ¼Ò¾Æû¼Ò³â°ú(¹ÚÂù¼® °¡Å縯ÀÇ´ë ¼øȯ±â³»°ú/³ª½Â¿ø ¿ï»êÀÇ´ë È£Èí±â³»°ú/¾È°æÁø °¡ÃµÀÇ´ë ¼Ò¾Æû¼Ò³â°ú) 
È޽Ġ11-02 ¼­¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °­´ç 16:05~16:25 Coffee break  () 
±³À°½Ã°£ 11-02 ¼­¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °­´ç 16:25~16:35 PH with uncorrected CHD  ¾ÈÈ¿¼ø(¼­¿ï´ë º¸¶ó¸Åº´¿ø ¼Ò¾Æ½ÉÀå°ú) 
±³À°½Ã°£ 11-02 ¼­¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °­´ç 16:35~16:45 PH with left heart disease  Á¤Çý¹®(°æÈñÀÇ´ë ½ÉÀå³»°ú) 
±³À°½Ã°£ 11-02 ¼­¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °­´ç 16:45~16:55 PH with connective disease  °­ÁöÇö(Àü³²ÀÇ´ë ·ù¸¶Æ¼½º³»°ú) 
±³À°½Ã°£ 11-02 ¼­¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °­´ç 16:55~17:05 PH with liver disease  À念¿ì(°¡ÃµÀÇ´ë ½ÉÀå³»°ú) 
±³À°½Ã°£ 11-02 ¼­¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °­´ç 17:05~17:15 PH with lung disease  ÀÌÀç½Â(¼­¿ï¾Æ»êº´¿ø È£Èí±â³»°ú) 
±³À°½Ã°£ 11-02 ¼­¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °­´ç 17:15~17:25 PH with post-operative CHD  À±ÀÚ°æ(¼¼Á¾º´¿ø ¼Ò¾Æ½ÉÀå°ú) 
Åä·Ð 11-02 ¼­¿ï¼º¸ðº´¿ø ÀÇ°úÇаü 2Ãþ °­´ç 17:25~17:45 Discussion  À¯½Â±â À»ÁöÀÇ´ë ¼øȯ±â³»°ú/¼­Çý¼± ¼øõÇâÀÇ´ë ¼øȯ±â³»°ú/±è¼öÇö ¼­¿ïÀÇ·á¿ø È£Èí±â³»°ú(À¯½Â±â À»ÁöÀÇ´ë ¼øȯ±â³»°ú/¼­Çý¼± ¼øõÇâÀÇ´ë ¼øȯ±â³»°ú/±è¼öÇö ¼­¿ïÀÇ·á¿ø È£Èí±â³»°ú) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ¼­¿ï¼º¸ðº´¿ø ´ëÇÑ°íÇ÷¾ÐÇÐȸ Æó°íÇ÷¾Ð¿¬±¸È¸ Á¦4ȸ Çмú¿¬·Ê½ÉÆ÷Áö¾ö : 2019-11-02""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û Â÷ÀÇ°úÇдëÇб³ºÐ´çÂ÷º´¿ø Â÷ÀÇ°úÇдëÇб³ ÀÓ»óÀÇÇÐ ½ÉÆ÷Áö¿ò(1) : 2019-11-02
´ÙÀ½±Û ¼¼ºê¶õ½ºº´¿ø Yonsei Lung Transplant Academy 2019 : 2019-11-02
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
150 ´ë±¸ ´ë±¸°¡Å縯´ëÇб³º´¿ø Ȳ¹ÝºÎÁ¾ ¹× Ȳ¹Ýº¯¼º : 2018-08-28 0 692 2018-07-28
149 ´ë±¸ ´ëÇѾȰúÇÐȸ 2018³â ´ë±¸ °æºÏ ¾È°ú Áöȸ Á¤±â ¿¬¼ö±³À° : 2018-08-28 0 704 2018-07-28
148 ºÎ»ê ½Å°æ¿µ»óÀÇÇÐÀÇ ÇмúÁõ·Ê¹ßÇ¥ : 2018-08-28 0 317 2018-07-28
147 ºÎ»ê ´ëÇÑÀ忬±¸ÇÐȸ Á¤±âÁý´ãȸ : 2018-08-27 0 567 2018-07-28
146 °æ±â ¾ÆÁÖ´ëÇб³º´¿ø ¼Ò¾ÆÀçÈ°ÀÇÇа­Á : 2018-08-26 0 603 2018-07-28
145 ´ëÀü 2018³â ´ëÇÑÅëÁõÇÐȸ Áö¹æ¼øȸ ÃÊÀ½ÆÄ ¹× °æ¸·¿Ü³»½Ã°æWorkshop_Cadaver Workshop : 2018-08-26 0 669 2018-07-28
144 ¼­¿ï °³¿ø 50Áֳ⠱â³ä Á¦ 9ȸ °­ºÏ»ï¼ºº´¿ø ´ç´¢Ç÷°ü¼¾ÅÍ ¿¬¼ö°­Á -´ç´¢º´ °ü¸® ¹× ÇÕº´Áõ ¿¹¹æÀ» À§ÇÑ 100³â ´ë°è : 2018-08-26 0 941 2018-07-28
143 ´ëÀü ´ëÇÑ°»³â±âÇÐȸ 2018 ÇÏ°è¿öÅ©¼¥ : 2018-08-26 0 639 2018-07-28
142 ¼­¿ï 2018³â ´ëÇÑ°ñ´ë»çÇÐȸ Á¦21Â÷ °ñ´Ù°øÁõ ¿¬¼ö°­Á : 2018-08-26 0 353 2018-07-28
141 ¼­¿ï Á¦16Â÷ ¼­¿ïƯº°½ÃÀÇ»çȸ Çмú´ëȸ : 2018-08-26 0 506 2018-07-28
140 ¼­¿ï Çѱ¹À¯¹æ¾ÏÇÐȸ 2018 School of Breast Disease (Day 2) : 2018-08-26 0 371 2018-07-28
139 ¼­¿ï ´ëÇÑÈĵÎÀ½¼º¾ð¾îÀÇÇÐȸ ¼º±Õ°üÀÇ´ë °­ºÏ»ï¼ºº´¿ø À̺ñÀÎÈÄ°ú 50Áֳ⠱â³ä ½ÉÆ÷Áö¿ò : 2018-08-26 0 503 2018-07-28
138 ¼­¿ï Á¦14ȸ ÀÓ»óÀÌ°úÇм¼¹Ì³ª(´ëÇÑÀ̺ñÀÎÈÄ°úÀÇ»çȸ&´ëÇÑÀÌÇÐȸ °øµ¿ÁÖ°ü) : 2018-08-26 0 653 2018-07-28
137 ¼­¿ï Áß¾Ó´ëÇб³º´¿ø Á¦4ȸ Áß¾Ó´ëÇб³ ¼Ò¾Æû¼Ò³â°ú ¿¬¼ö°­Á : 2018-08-26 0 478 2018-07-28
136 ¼­¿ï ¼¼ºê¶õ½ºº´¿ø 13th Yonsei Foot & Ankle Cadaveric Workshop : 2018-08-26 0 409 2018-07-28
1391 | 1392 | 1393 | 1394 | 1395 | 1396 | 1397 | 1398 | 1399 | 1400
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷